Cumberland Pharmaceuticals (CPIX) Profit After Tax (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Profit After Tax data on file, last reported at -$3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 361.69% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$7.4 million (down 126.74% YoY), and the FY2025 full-year result was -$2.8 million, up 56.23% from the prior year.
• Profit After Tax fell to -$3.3 million in Q1 2026, from -$1.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.3 million in Q1 2025 to a low of -$6.3 million in Q4 2023.
• A 5-year average of -$1.4 million and a median of -$1.4 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax slumped 1204.25% in 2024 and surged 166.08% in 2025, its largest moves.
• Tracing CPIX's Profit After Tax over 5 years: stood at -$2.4 million in 2022, then sank by 158.2% to -$6.3 million in 2023, then soared by 69.82% to -$1.9 million in 2024, then grew by 24.87% to -$1.4 million in 2025, then slumped by 130.26% to -$3.3 million in 2026.
• Business Quant data shows CPIX's Profit After Tax at -$3.3 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.9 million in Q3 2025.